Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Opthea Ltd (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OPT
Nasdaq
8731
https://opthea.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Opthea Ltd (ADR)
Opthea to Present at the OIS Retina Innovation Summit at ARVO
- Apr 25th, 2024 1:00 pm
Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT),
- Apr 12th, 2024 8:49 pm
Opthea Appoints John Han, PharmD, as VP Medical Affairs
- Apr 8th, 2024 10:42 pm
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
- Apr 4th, 2024 10:34 pm
Opthea Appoints Sujal Shah to the Board of Directors
- Apr 3rd, 2024 9:39 pm
7 Growth Stocks to Buy to Outperform the Nasdaq Index
- Apr 3rd, 2024 1:53 pm
11 Best ASX Stocks To Buy Now
- Mar 24th, 2024 11:55 am
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
- Mar 19th, 2024 10:00 am
Opthea to Participate in the Leerink Partners Global Biopharma Conference
- Mar 5th, 2024 10:08 pm
Opthea Reports Half-Year Financial Results and Business Updates
- Feb 28th, 2024 10:55 pm
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
- Feb 19th, 2024 11:25 pm
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
- Feb 14th, 2024 12:00 pm
10 Best Australian Stocks To Buy
- Feb 5th, 2024 8:11 am
Opthea Strengthens Team with Key Clinical and Regulatory Hires
- Feb 1st, 2024 11:00 am
Opthea to Receive US$35M Commitment and Additional US$50M Funding
- Dec 27th, 2023 11:00 am
Opthea Receives A$8.8 million R&D Tax Incentive
- Dec 19th, 2023 11:00 am
Opthea to Present at the FLORetina 2023 Congress
- Dec 1st, 2023 10:30 am
Opthea to Present at the Jefferies 2023 London Healthcare Conference
- Nov 9th, 2023 10:30 am
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
- Oct 30th, 2023 9:30 am
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
- Oct 27th, 2023 9:30 am
Scroll